Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma

BACKGROUND: Compared with single‐drug TACE, our previous phase III study demonstrated that triple‐drug transarterial chemoembolization (TACE) prolonged overall survival (OS) in patients with unresectable hepatocellular carcinoma (HCC). The aim of this study was to find which patients can benefit fro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Med
Asıl Yazarlar: He, MinKe, Li, Qing, Shen, JingXian, Tan, GuoSheng, Li, QiJiong, Lai, JiaYing, Wei, Wei, Zhang, YaoJun, Zou, RuHai, Chen, MinShan, Guo, RongPing, Shi, Ming
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2019
Konular:
Clinical Cancer Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6675716/
https://ncbi.nlm.nih.gov/pubmed/31207163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2355
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller